Marija Stanišić, Milica Crnoglavac Popović, Marko Radenković, Branimir Bajac, Vojin Tadić, Olivera Prodanović, Radivoje Prodanović
{"title":"Biomimetic mineralization of chemically modified glucose oxidase from Aspergillus niger in ZIF-8.","authors":"Marija Stanišić, Milica Crnoglavac Popović, Marko Radenković, Branimir Bajac, Vojin Tadić, Olivera Prodanović, Radivoje Prodanović","doi":"10.1007/s10529-026-03722-8","DOIUrl":null,"url":null,"abstract":"<p><p>Chemical surface modification of enzymes represents a powerful strategy to improve immobilization and catalytic performance. In this study, glucose oxidase (GOx) from Aspergillus niger was chemically modified via periodate oxidation and reductive amination to incorporate L-aspartate (D-GOx) and L-histidine (H-GOx) residues. These modifications enhanced electrostatic and coordinative interactions with Zn<sup>2+</sup> and 2-methylimidazole during biomimetic mineralization, leading to efficient encapsulation in ZIF-8 frameworks. The resulting D-GOx@ZIF-8 and H-GOx@ZIF-8 biocomposites showed significantly improved activity and stability compared to native GOx. H-GOx@ZIF-8 achieved a specific activity of 4551 IU/g, representing a sixfold increase over previously reported systems. Both modified biocomposites also demonstrated greater resistance to detergent washing and retained higher activity after exposure to 65 °C, indicating stronger incorporation into the ZIF-8 matrix. These results highlight the dual advantage of introducing negatively charged and imidazole-functional groups for promoting biomineralization and improving biocatalyst robustness. This strategy provides a mild, scalable route for preparing enzyme@MOF composites with enhanced operational stability, offering direct potential for industrial bioprocesses, continuous-flow catalysis, and biosensing applications.</p>","PeriodicalId":8929,"journal":{"name":"Biotechnology Letters","volume":"48 2","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Letters","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10529-026-03722-8","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Chemical surface modification of enzymes represents a powerful strategy to improve immobilization and catalytic performance. In this study, glucose oxidase (GOx) from Aspergillus niger was chemically modified via periodate oxidation and reductive amination to incorporate L-aspartate (D-GOx) and L-histidine (H-GOx) residues. These modifications enhanced electrostatic and coordinative interactions with Zn2+ and 2-methylimidazole during biomimetic mineralization, leading to efficient encapsulation in ZIF-8 frameworks. The resulting D-GOx@ZIF-8 and H-GOx@ZIF-8 biocomposites showed significantly improved activity and stability compared to native GOx. H-GOx@ZIF-8 achieved a specific activity of 4551 IU/g, representing a sixfold increase over previously reported systems. Both modified biocomposites also demonstrated greater resistance to detergent washing and retained higher activity after exposure to 65 °C, indicating stronger incorporation into the ZIF-8 matrix. These results highlight the dual advantage of introducing negatively charged and imidazole-functional groups for promoting biomineralization and improving biocatalyst robustness. This strategy provides a mild, scalable route for preparing enzyme@MOF composites with enhanced operational stability, offering direct potential for industrial bioprocesses, continuous-flow catalysis, and biosensing applications.
期刊介绍:
Biotechnology Letters is the world’s leading rapid-publication primary journal dedicated to biotechnology as a whole – that is to topics relating to actual or potential applications of biological reactions affected by microbial, plant or animal cells and biocatalysts derived from them.
All relevant aspects of molecular biology, genetics and cell biochemistry, of process and reactor design, of pre- and post-treatment steps, and of manufacturing or service operations are therefore included.
Contributions from industrial and academic laboratories are equally welcome. We also welcome contributions covering biotechnological aspects of regenerative medicine and biomaterials and also cancer biotechnology. Criteria for the acceptance of papers relate to our aim of publishing useful and informative results that will be of value to other workers in related fields.
The emphasis is very much on novelty and immediacy in order to justify rapid publication of authors’ results. It should be noted, however, that we do not normally publish papers (but this is not absolute) that deal with unidentified consortia of microorganisms (e.g. as in activated sludge) as these results may not be easily reproducible in other laboratories.
Papers describing the isolation and identification of microorganisms are not regarded as appropriate but such information can be appended as supporting information to a paper. Papers dealing with simple process development are usually considered to lack sufficient novelty or interest to warrant publication.